NuVitality Labs enters $60 billion weight loss market with 3 new products

NEW YORK, Jan. 9, 2012 /CNW/ - EMO CAPITAL CORP (NUVI:OTCBB) NuVitality Labs, a wholly owned subsidiary of EMO Capital is pleased to announce three new products to its growing catalogue. The additional new products will focus on weight loss and healthy lifestyles. January always marks a personal commitment to weight loss and with these new products NuVitality plans to capitalize not just on this annual push but on the global epidemic that is obesity.

Globally over 1 billion adults are deemed obese and when the entire population is considered this number balloons to 1.5 billion people.  In the USA alone the amount of money spent on diet and weight loss alone has doubled in the past 20 years to $60 billion a YEAR!*

NuVitality is pleased to announce its three products for consumers and agents alike:

NuBerry Blast http://nuvitalitylabs.com/nuberryblast.html

NuAfrican Mango Max  http://nuvitalitylabs.com/nuafricanmangomax.html

NuCleanse Max   http://nuvitalitylabs.com/nuafricanmangomax.html

Emo Capital Corp through its wholly owned subsidiary NuVitality Labs is a direct  marketing corporation specializing in health and wellness categories. www.emocapitalcorp.com

Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend", "dramatically" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Emo Capital's filings with the Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to the ability of the company to control product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on Emo Capitals's website does not constitute a part of this release.

*http://www.worldometers.info/weight-loss/

Investor Relations
Phone: [phone]